CompletedPhase 4ketamine
Ketamine Versus Etomidate During Rapid Sequence Intubation: Consequences on Hospital Morbidity
Sponsored by Assistance Publique - Hôpitaux de Paris
NCT ID
NCT00440102
Target Enrollment
655 participants
Start Date
2007-04
Est. Completion
2008-03
About This Study
The expected benefit is a reduction of the morbidity of patients admitted in the intensive care unit having received ketamine for intubation.
Conditions Studied
Interventions
- •Ketamine
- •Etomidate
Eligibility
Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Patient requiring sedation for prehospital endotracheal intubation * Age ≥ 18 years * Consent of a family member if present, then of the patient for the pursuit of research Exclusion Criteria: * Patient in cardiac arrest * Presence of contraindication to succinylcholine: * Personal or familial history of malignant hyperthermia * Known hypersensitivity to succinylcholine * Skeletal muscle disease * Myasthenia * Known hyperkalemia * Severe ophthalmic injury * Known congenital deficit in plasmatic pseudo-cholinesterase * Presence of contraindication to ketamine: * Known hypersensitivity to ketamine * Known porphyria * Severe hypertension * Presence of contraindication to etomidate: * Known untreated adrenal insufficiency * Known hypersensitivity to etomidate * Known pregnancy * Unaffiliated patient to the social insurance
Study Locations (1)
Chu Avicenne
Bobigny, France